Wikio - Drug Manufacturers

Boss of drug firm behind cervical cancer jabs for schoolgirls is on board of Ofsted (Daily Mail)

Sat, 05 Jul 2008 23:53:10 GMT

Schools Secretary Ed Balls is at the centre of a controversy over the appointment of a top executive with a drugs company to the board of education watchdog Ofsted.

Source : Daily Mail (subscribe)

Explore : Cancers, Cervical Cancer

Boss of drug firm behind cervical cancer jabs for schoolgirls is on board of Ofsted (Daily Mail on Sunday)

Sat, 05 Jul 2008 23:48:33 GMT

Schools Secretary Ed Balls is at the centre of a controversy over the appointment of a top executive with a drugs company to the board of education watchdog Ofsted.

Source : Daily Mail on Sunday (subscribe)

Explore : Cancers, Cervical Cancer

Boss of drug firm behind cervical cancer jabs for schoolgirls is on board of Ofsted (Evening Standard)

Sat, 05 Jul 2008 21:54:51 GMT

Schools Secretary Ed Balls is at the centre of a controversy over the appointment of a top executive with a drugs company to the board of education watchdog Ofsted.

Source : Evening Standard (subscribe)

Explore : Cancers, Cervical Cancer

Diet pill maker targets competition (Houston Chronicle)

Sun, 06 Jul 2008 05:30:00 GMT

If pharmaceutical giant GlaxoSmithKline has its way, many diet products could be yanked from the market.

Source : Houston Chronicle (subscribe)

Explore : Glaxosmithkline, Health Industries, US

A Record Year for the Pharmaceutical Lobby in ‘07: Washington’s largest lobby racks up another banner year on Capitol Hill (Docuticker)

Sat, 05 Jul 2008 18:39:30 GMT

A Record Year for the Pharmaceutical Lobby in ‘07: Washington’s largest lobby racks up another banner year on Capitol Hill Source: The Center for Public Integrity Washington’s largest lobby, the pharmaceutical industry, racked up another banner year on Capitol Hill in 2007, backed by a record $168 million lobbying effort, according to a Center for [...]

Source : Docuticker (subscribe)

Explore : Health, Health Industries, Pharmaceutical Industry

Rosiglitazone (HotMed.info)

Sat, 05 Jul 2008 06:56:25 GMT

Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Recent findings suggest that Rosiglitazone is associated with a statistically significant risk of myocardial ischemic events.[1][2] Pharmacology Like...

Source : HotMed.info (subscribe)

Explore : Glaxosmithkline

Wyeth, Progenics Drug Clears EC (Contract Pharma Breaking News)

Fri, 04 Jul 2008 11:41:00 GMT

Relistor subcutaneous injection, a treatment for opioid-induced constipation (OIC), has been approved by the European Commission. The drug, developed by Wyeth and Progenics , is now approved in the 27 member states of the European Union as well as Iceland, Norway, and Liechtenstein. Relistor is the first approved treatment for OIC in the European Union. "The approval of Relistor by the European Commission...

Source : Contract Pharma Breaking News (subscribe)

Explore : European Commission, Wyeth

Your Journey has ended. (Info Lowongan Kerja)

Fri, 04 Jul 2008 08:28:00 GMT

Activist filmmaker Michael Moore turns his attentions towards the topic of health care in the United States in this documentary that weighs the plight of the uninsured against the record profits of the pharmaceutical industry. ROLEX 145.- EURO OMEGA All top brands with many models are available at : All top brands with over 1'835 models are available at: http://qxajiu.tawertagyes.com...

Source : Info Lowongan Kerja (subscribe)

Explore : Cinema, Directors, Health, Health Industries, Pharmaceutical Industry

Judge urges Eli Lilly to settle Zyprexa lawsuit (Seattle Times)

Fri, 04 Jul 2008 07:00:00 GMT

A federal judge in New York is urging Eli Lilly and Co. to settle a multibillion-dollar lawsuit filed by insurance companies, unions and others who claim the pharmaceutical giant overpriced its top-selling drug Zyprexa and exaggerated its usefulness.

Source : Seattle Times (subscribe)

Explore : Business, Cities and Towns, Eli Lilly, New York, New York City

GSK, Novartis plan to appeal verdict (News & Observer)

Fri, 04 Jul 2008 05:30:00 GMT

Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for prescription drugs.

Source : News & Observer (subscribe)

Explore : Business, Novartis

Former Beaver County pharmacist sentenced in prescriptions fraud (Today's Tribune-Review)

Fri, 04 Jul 2008 04:42:20 GMT

A former Beaver County pharmacist was sentenced to 57 months in federal prison for bilking the state Medicaid program, insurance companies and drug manufacturers through fake transactions.

Source : Today's Tribune-Review (subscribe)

Judge urges Eli Lilly to settle Zyprexa lawsuit (Miami Herald)

Fri, 04 Jul 2008 03:39:56 GMT

Source : Miami Herald (subscribe)

Explore : Cities and Towns, Eli Lilly, New York, New York City

Judge urges Eli Lilly to settle Zyprexa lawsuit (Examiner)

Fri, 04 Jul 2008 03:09:45 GMT

Source : Examiner (subscribe)

Explore : Business, Cities and Towns, Eli Lilly, New York, New York City

Judge urges Eli Lilly to settle Zyprexa lawsuit (kansascity.com)

Fri, 04 Jul 2008 03:00:00 GMT

Source : kansascity.com (subscribe)

Explore : Cities and Towns, Eli Lilly, Kansas, New York, New York City

Judge urges Eli Lilly to settle multibillion fraud lawsuit over top-selling drug Zyprexa (Star Tribune)

Fri, 04 Jul 2008 02:55:06 GMT

INDIANAPOLIS - A federal judge in New York is urging Eli Lilly and Co. to settle a multibillion-dollar lawsuit filed by insurance companies, unions and others who claim the pharmaceutical giant overpriced its top-selling drug Zyprexa and exaggerated its usefulness.In a 290-page discussion draft, U.S. District Judge Jack Weinstein said he was prepared to grant class-action status for the lawsuit brought...

Source : Star Tribune (subscribe)

Explore : Business, Eli Lilly

Judge urges Eli Lilly to settle Zyprexa lawsuit (San Fransisco Chronicle)

Fri, 04 Jul 2008 02:53:43 GMT

Source : San Fransisco Chronicle (subscribe)

Explore : Business, Cities and Towns, Eli Lilly, New York, New York City

Judge urges Eli Lilly to settle Zyprexa lawsuit (The Washington Times)

Fri, 04 Jul 2008 02:53:04 GMT

Source : The Washington Times (subscribe)

Explore : Business, Cities and Towns, Eli Lilly, New York, New York City

Judge urges Eli Lilly to settle Zyprexa lawsuit (Seattle Post-Intelligencer)

Fri, 04 Jul 2008 02:52:00 GMT

INDIANAPOLIS -- A federal judge in New York is urging Eli Lilly and Co. to settle a multibillion-dollar lawsuit filed by insurance companies, unions and others who claim the pharmaceutical giant overpriced its top-selling drug Zyprexa and exaggerated its usefulness.

Source : Seattle Post-Intelligencer (subscribe)

Explore : Business, Eli Lilly, Indianapolis, New York, New York City

Field of Dreams:opiates vs. GlaxoSmithKline: poppies win so did the scientist (soulful sepulcher)

Fri, 04 Jul 2008 02:02:00 GMT

This is a remarkable story I found at the Seroxat Sufferers Stand Up and Be counted blog, about a scientist who left his job with GSK to start a rival company that uses the extraction of opiate alkaloids from Tasmanian poppies for use in pain-relief drugs such as morphine. From the article: "The industry at the heart of the dispute is the extraction of opiate alkaloids from Tasmanian poppies

Source : soulful sepulcher (subscribe)

Explore : Glaxosmithkline, Mental Health

GlaxoSmithKline, Novartis to appeal $114 million verdict in Alabama drug price lawsuits (Star Tribune)

Thu, 03 Jul 2008 22:29:11 GMT

The jury returned the judgments Tuesday following a trial of more than two weeks in Montgomery County Circuit Court. It was the second trial of the state's lawsuits against more than 70 drug companies accusing them of causing the Medicaid program to pay too much for prescription drugs.

Source : Star Tribune (subscribe)

Explore : Alabama, Business, Glaxosmithkline, Novartis